BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2842825)

  • 1. [Fabry's disease. Presentation of a case].
    Anasagasti I; Yerobi JA; Amato E; Poza J
    Rev Clin Esp; 1988 Mar; 182(4):236. PubMed ID: 2842825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fabry's disease. Apropos of a family].
    Guízar-Vázquez J; Calva-Mercado MP; Rodríguez-Budelli M; Zetina-Rosales ME; García-Escobar BE; González-Noriega A; Salamanca-Gómez F
    Bol Med Hosp Infant Mex; 1985 Aug; 42(8):494-6. PubMed ID: 2996568
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of Fabry's disease.
    Miura M; Tomino Y; Inoue W; Endoh M; Suga T; Kaneshige H; Nomoto Y; Sakai H; Matsuo I; Nagura H; Ikeda N
    Tokai J Exp Clin Med; 1983 Jan; 8(1):23-9. PubMed ID: 6310828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry's disease in a heterozygous woman.
    Rodriguez FH; Hoffmann EO; Ordinario AT; Baliga M
    Arch Pathol Lab Med; 1985 Jan; 109(1):89-91. PubMed ID: 2982342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
    Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
    Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiokeratoma corporis diffusum (Fabry's disease). Update. Apropos of 2 cases].
    Larralde de Luna M; García Díaz R; Sánchez G; Ilari R; Pierini AM; Campoy C; Chamoles NH
    Med Cutan Ibero Lat Am; 1985; 13(2):129-40. PubMed ID: 2995736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Fabry's disease. An oligosymptomatic variant.
    Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH
    Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-galactosidase A deficiency (Fabry's disease) in a black Zimbabwean.
    Borok MZ; Gabriel R
    S Afr Med J; 1993 May; 83(5):350-1. PubMed ID: 8211434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffuse Fabry's angiokeratoma].
    Trofimova IB; Aĭvazian AA
    Vestn Dermatol Venerol; 1983 Jan; (1):54-7. PubMed ID: 6299021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperintensity in the anterior region of the temporal lobes in Fabry's disease].
    Mendióroz M; Jericó-Pascual I; Méndez I; Gastón-Zubimendi I; Arteaga J; Montaner J
    Rev Neurol; 2009 Jun 1-15; 48(11):599-600. PubMed ID: 19472159
    [No Abstract]   [Full Text] [Related]  

  • 11. On the diagnosis of Fabry's disease.
    Wadskov S; Andersen V; Kobayasi T; Søondergaard J; Søorensen SA
    Acta Derm Venereol; 1975; 55(5):363-6. PubMed ID: 52972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
    Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
    Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foetal liver transplant in Fabry's disease.
    Malik MC; Touraine JL; Perrot H; Traeger J
    Proc Eur Dial Transplant Assoc; 1979; 16():413-8. PubMed ID: 95047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fabry's disease as a cause of chronic renal failure].
    Marchelek M; Rózański J; Ciechanowski K
    Pol Arch Med Wewn; 2004 May; 111(5):625-8. PubMed ID: 15508816
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
    Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An atypical variant of Fabry's disease with manifestations confined to the myocardium.
    von Scheidt W; Eng CM; Fitzmaurice TF; Erdmann E; Hübner G; Olsen EG; Christomanou H; Kandolf R; Bishop DF; Desnick RJ
    N Engl J Med; 1991 Feb; 324(6):395-9. PubMed ID: 1846223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enzyme replacement therapy in Fabry's disease].
    Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
    Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
    Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
    Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
    Yuasa T; Fukuma M; Takashima S; Takaki R
    Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
    Selgas R; García de Lorenzo A; Valdés F; Beck M
    Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.